Leal Health

Company Overview

Snapshot

Founded in December 2017 by Tzvia Bader, Guy Gildor, and Avital Gaziel, Leal Health operates with 11–50 employees. The company has raised $54.2M across 6 funding rounds from 8 investors. In February 2026, Leal Health was acquired by Nexus Precision Health.

Business overview

Leal Health is an AI-powered decision support platform focused on accelerating access to advanced cancer treatments. The company works with patients, healthcare providers, and pharmaceutical companies to offer instant access to precise cancer treatments. Its technology also supports the pharmaceutical and biotech industries in developing patient-centric clinical trials and provides real-time analytics on patient barriers and motivations. Leal Health operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Engagement, leveraging artificial intelligence and software platforms.

Strategic signal

Leal Health was acquired by Nexus Precision Health in February 2026, signaling a strategic move to accelerate precision medicine at scale. This acquisition indicates a strong validation of Leal Health's AI-powered platform and its potential to integrate into broader precision health initiatives, suggesting a significant expansion of its market reach and impact within the healthcare industry.

Company Intelligence Q&A

What was a significant recent corporate development for Leal Health?

In February 2026, Leal Health was acquired by Nexus Precision Health. This acquisition aims to accelerate precision medicine at scale by integrating Leal Health's AI-powered decision support platform.

When did Leal Health receive a grant for its patient recruitment tool?

In September 2021, Leal Health, then operating as TrialJectory, received a grant from the.

What recognition did Leal Health receive in 2020?

In November 2020, TIME magazine selected Leal Health's AI-powered clinical trial-matching platform for its '100 Best Inventions of 2020' list, highlighting its innovative approach to connecting cancer patients with clinical trials.

Which investors participated in Leal Health's February 2022 funding round?

In February 2022, Leal Health secured funding from investors including lead investor.

How has Leal Health incorporated generative AI into its platform?

In December 2023, Leal Health enhanced its patient platform by integrating generative AI, aiming to boost its capabilities in providing decision support for cancer treatment.